why choose us

Clinical Trials Search

Showing 11,330 of 132,366 result(s)
Attentional Bias Modification in Fibromyalgia Patients (ABM)

Status: COMPLETED

Condition: Fibromyalgia

Interventions: Direct attention away from pain-related information (i.e., facial expressions) through implicit training procedures

Date: 2023-05-30

The INVADER™ Percutaneous Transluminal Coronary Angioplasty (PTCA) Post Market Clinical Follow-up (PMCF) Study

Status: COMPLETED

Condition: Coronary Artery Disease

Interventions: INVADER™ PTCA Balloon Dilatation Catheter is a single use, EO sterilized, monorail rapid exchange (RX) coronary angioplasty balloon dilatation cathete

Date: 2023-05-30

Evaluation of Renal Protection Of Dexmedetomidine Versus Midazolam As a Sedative For Septic Patients In Intensive Care Unit

Status: Completed

Condition: Renal Failure

Interventions: midazolam infusion by 0.03-0.3mg;kg in increments of 1-2.5mg followed by Maintenance dose: 0.03-0.2mg;kg;hour
for midazolam.

Date: 2023-05-30

The Socket Shield Technique, a Prospective Cohort Study of 20 Patients

Status: COMPLETED

Condition: Peri-implant Health

Interventions: tooth is split in socket shield configuration, implant is immediately placed

Date: 2023-05-30

Reduction Nymphoplasty: Assessment of the Impact on Sexuality, Self-Esteem and Screening for Dysmorphophobia

Status: Completed

Condition: Plastic Surgery

Interventions: Female Sexual Function Index questionnaire

Date: 2023-05-30

Immunogenicity and Safety of Recombinant Zoster Vaccine in People Living With HIV

Status: NOT_YET_RECRUITING

Condition: Vaccination; Infection

Interventions: Two doses of recombinant zoster vaccine(Shingrix®), 2 months apart

Date: 2023-05-30

Yoga for Treatment of Overactive Bladder in Pediatric Patients

Status: Completed

Condition: Overactive Bladder

Interventions: Restorative Vinyasa Yoga

Date: 2023-05-30

How to Reduce Suicidal Thoughts and Impulsivity in Depression

Status: NOT_YET_RECRUITING

Condition: Unipolar Depression

Interventions: 20 active tDCS sessions (4 sessions;day for 5 days, 30 min each, 2 mA) applied to the left DLPFC

Date: 2023-05-30

Pembrolizumab and Chemotherapy Neoadjuvant;Adjuvant of NSCLC

Status: NOT_YET_RECRUITING

Condition: Stage IIIB(N2) Non-small Cell Lung Cancer

Interventions:

Biological: Pembrolizumab 200 mg IV infusion

Drug: nab-paclitaxel IV infusion

Drug: Carboplatin IV infusion

Drug: Pemetrexed IV i

Date: 2023-05-30

A Study of the Genetic Basis of Response to Growth Hormone Treatment in Children With Idiopathic Short Stature

Status: NOT_YET_RECRUITING

Condition: Idiopathic Short Stature

Interventions: No treatment is provided to the participants as part of this study.

Date: 2023-05-30